Celgene Corporation (NASDAQ:CELG) | Ex-Celgene Executive Gets 16-Month Term for Insider Trading

[at Bloomberg] – A former Celgene Corp. (CELG) director of financial reporting was sentenced to 16 months in prison for insider trading after his lawyer said he was a nerd who wasn’t motivated . . . → Read More: Celgene Corporation (NASDAQ:CELG) | Ex-Celgene Executive Gets 16-Month Term for Insider Trading Similar Articles: Market Update (NASDAQ:CELG): Celgene Corporation to Announce First Quarter 2014 Results on April 24, 2014 Celgene Corporation (NASDAQ:CELG) – U.S. FDA approves Celgene drug for psoriatic arthritis Stock Update: Celgene Corporation (NASDAQ:CELG) – Celgene weakness due to short-term trading dynamics, says RBC Capital
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.